Helicobacter pylori: Usefulness of an empirical fourth-line rifabutin-based regimen

Expert Review of Gastroenterology and Hepatology

Volumn 6, Issue 4, 2012, Pages 437-439

  D'Elios, Mario M ^a   Silvestri, Elena ^a   Emmi, Giacomo ^a   Barnini, Tommaso ^a   Prisco, Domenico ^a  

^a CAREGGI UNIVERSITY HOSPITAL   (Italy)

Author keywords

antibiotics; eradication; gastric cancer; Helicobacter pylori; peptic ulcer; rescue therapy; rifabutin

Indexed keywords

AMOXICILLIN; BISMUTH; CLARITHROMYCIN; LEVOFLOXACIN; METRONIDAZOLE; PROTON PUMP INHIBITOR; RIFABUTIN; TETRACYCLINE;

ABDOMINAL PAIN; ANOREXIA; ANTIBIOTIC RESISTANCE; APHTHOUS STOMATITIS; ASTHENIA; BONE MARROW TOXICITY; DIARRHEA; DRUG EFFICACY; DRUG FEVER; DRUG INDUCED HEADACHE; DRUG TREATMENT FAILURE; DYSPEPSIA; ERADICATION THERAPY; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; HYPERTRANSAMINASEMIA; LEUKOPENIA; METALLIC TASTE; MYALGIA; NAUSEA; PATIENT COMPLIANCE; PEPTIC ULCER; REVIEW; SIDE EFFECT; STOMACH CANCER; TASTE; THROMBOCYTOPENIA; UREA BREATH TEST; VOMITING;

EID: 84865790384     PISSN: 17474124     EISSN: 17474132     Source Type: Journal    
DOI: 10.1586/egh.12.32     Document Type: Review

References (16)

1. Gisbert JP, Castro-Fernandez M, Perez-Aisa A et al. Fourth-line rescue therapy with rifabutin in patients with three Helicobacter pylori eradication failures. Aliment. Pharmacol. Ther. 35(8), 941-947 (2012).
2. McColl KE. Clinical practice. Helicobacter pylori infection. N. Engl. J. Med. 362(17), 1597-1604 (2010).
3. Gisbert JP, Pajares JM. Review article: Helicobacter pylori "rescue" regimen when proton pump inhibitor-based triple therapies fail. Aliment. Pharmacol. Ther. 16(6), 1047-1057 (2002). (Pubitemid 34680746)
4. Gisbert JP, Castro-Fernández M, Bermejo F et al.; H. pylori Study Group of the Asociación Española de Gastroenterología. Third-line rescue therapy with levofloxacin after two H. pylori treatment failures. Am. J. Gastroenterol. 101(2), 243-247 (2006). (Pubitemid 43381662)
5. Gisbert JP, Pajares JM. Helicobacter pylori "rescue" therapy after failure of two eradication treatments. Helicobacter 10(5), 363-372 (2005). (Pubitemid 41368693)
6. Graham DY, Fischbach LA. Empiric therapies for Helicobacter pylori infections. CMAJ 183(9), E506-E508 (2011).
7. Perri F, Festa V, Clemente R, Quitadamo M, Andriulli A. Rifabutin-based 'rescue therapy' for Helicobacter pylori infected patients after failure of standard regimens. Aliment. Pharmacol. Ther. 14(3), 311-316 (2000). (Pubitemid 30145319)
8. Canducci F, Ojetti V, Pola P, Gasbarrini G, Gasbarrini A. Rifabutin-based Helicobacter pylori eradication 'rescue therapy'. Aliment. Pharmacol. Ther. 15(1), 143 (2001). (Pubitemid 32055595)
9. Miehlke S, Schneider-Brachert W, Kirsch C et al. One-week once-daily triple therapy with esomeprazole, moxifloxacin, and rifabutin for eradication of persistent Helicobacter pylori resistant to both metronidazole and clarithromycin. Helicobacter 13(1), 69-74 (2008).
10. Van der Poorten D, Katelaris PH. The effectiveness of rifabutin triple therapy for patients with difficult-toeradicate Helicobacter pylori in clinical practice. Aliment. Pharmacol. Ther. 26(11-12), 1537-1542 (2007). (Pubitemid 350178803)
11. van Zanten SV, Desai S, Best L et al. Rescue therapy using a rifabutin-based regimen is effective for cure of Helicobacter pylori infection. Can. J. Gastroenterol. 24(5), 303-306 (2010).
12. Gisbert JP, Calvet X. Review article: rifabutin in the treatment of refractory Helicobacter pylori infection. Aliment. Pharmacol. Ther. 35(2), 209-221 (2012).
13. Bock H, Koop H, Lehn N, Heep M. Rifabutin-based triple therapy after failure of Helicobacter pylori eradication treatment: preliminary experience. J. Clin. Gastroenterol. 31(3), 222-225 (2000).
14. Borody TJ, Pang G, Wettstein AR et al. Efficacy and safety of rifabutin-containing 'rescue therapy' for resistant Helicobacter pylori infection. Aliment. Pharmacol. Ther. 23(4), 481-488 (2006). (Pubitemid 43382002)
15. Malfertheiner P, Megraud F, O'Morain CA et al.; European Helicobacter Study Group. Management of Helicobacter pylori infection - The Maastricht IV/ Florence Consensus Report. Gut 61(5), 646-664 (2012).
16. Costa F, D'Elios MM. Management of Helicobacter pylori infection. Expert Rev. Anti. Infect. Ther. 8(8), 887-892 (2010).